This policy insight examines the unexpected drop in Medicare’s per-beneficiary spending projections and its implications for beneficiaries and the program’s future.
- state & global data
- view as grid
- view as list
On Monday, July 14, 2014, the Kaiser Family Foundation and the Alliance for Health Reform will host a briefing to discuss CHIP, and why it was created, as well as experiences with children’s coverage through CHIP and Medicaid, and some of the key policy and financing questions around children’s health coverage looking forward.
This report examines a new measure of Medicare’s financial health established by the Medicare Prescription Drug, Improvement and Modernization Act of 2003 (MMA). The report, authored by Marilyn Moon, takes an in-depth look at the program’s new solvency test, which measures general revenues as a share of total Medicare spending and can trigger a “funding warning” that compels the President to propose and the Congress to consider a funding warning.
This budget analysis reviews U.S. funding for global health programs included in the fiscal year 2015 Budget Request released on March 4, 2014. It examines funding by program area as well as trends over time.
This blog post discusses Sovaldi (sofosbuvir), an oral drug recently approved by the FDA for the treatment of chronic hepatitis C, and the potential impact of this long-awaited cure on Medicare spending and Part D premiums.